Cellectis (CLLS) Exchange Rate Effect (2014 - 2026)
Cellectis (CLLS) posted Exchange Rate Effect of -$33.2 million for Q1 2026, down 2577.39% on a QoQ basis from $1.3 million in Q4 2025, and up 10.93% year-over-year from -$29.9 million in Q1 2025.
Cellectis (CLLS) has 13 years of Exchange Rate Effect data on file, last reported at -$33.2 million in Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 10.93% year-over-year to -$33.2 million; the TTM figure through Mar 2026 stood at -$33.2 million (up 10.93% YoY), while the FY2025 annual figure was -$33.3 million, up 15.73% from the prior year.
- Exchange Rate Effect retreated to -$33.2 million in Q1 2026, from $1.3 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $2.0 million in Q4 2022 and bottomed at -$38.1 million in Q2 2024.
- A 5-year average of -$23.8 million and a median of -$33.2 million in 2026 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect surged 184.23% — and 2024, when it plunged 5666.97%.
- Year by year, Exchange Rate Effect stood at $2.0 million in 2022, then decreased by 14.36% to $1.7 million in 2023, then tumbled by 220.46% to -$2.1 million in 2024, then soared by 165.21% to $1.3 million in 2025, then plunged by 2577.39% to -$33.2 million in 2026.
- The last three Exchange Rate Effect figures came in at -$33.2 million (Q1 2026), $1.3 million (Q4 2025), and -$32.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | -33.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -217,000.00 |
| Mar 31, 2026 | -217,000.00 |
| Dec 31, 2025 | 1.34 Mn |
| Dec 31, 2025 | 1.34 Mn |
| Sep 30, 2025 | -32.73 Mn |
| Sep 30, 2025 | -32.73 Mn |
| Jun 30, 2025 | -33.89 Mn |
| Jun 30, 2025 | -33.89 Mn |
| Mar 31, 2025 | -37.27 Mn |
| Mar 31, 2025 | -37.27 Mn |
| Dec 31, 2024 | -2.06 Mn |
| Dec 31, 2024 | -2.06 Mn |
| Sep 30, 2024 | -35.15 Mn |
| Sep 30, 2024 | -35.15 Mn |
| Jun 30, 2024 | -38.08 Mn |
| Jun 30, 2024 | -38.08 Mn |
| Mar 31, 2024 | -37.24 Mn |
| Mar 31, 2024 | -37.24 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | -37.51 Mn |
| Sep 30, 2023 | -37.51 Mn |
| Jun 30, 2023 | -37.05 Mn |
| Jun 30, 2023 | -37.05 Mn |
| Mar 31, 2023 | 669,000.00 |
| Mar 31, 2023 | 669,000.00 |
| Dec 31, 2022 | 1.99 Mn |
| Dec 31, 2022 | 1.99 Mn |
| Sep 30, 2022 | -35.43 Mn |
| Sep 30, 2022 | -35.43 Mn |
| Jun 30, 2022 | -29.63 Mn |
| Jun 30, 2022 | -29.63 Mn |
| Mar 31, 2022 | -21.26 Mn |
| Mar 31, 2022 | -21.26 Mn |
| Dec 31, 2021 | -2.37 Mn |
| Dec 31, 2021 | -2.37 Mn |
| Sep 30, 2021 | -14.35 Mn |
| Sep 30, 2021 | -14.35 Mn |
| Jun 30, 2021 | -9.60 Mn |
| Jun 30, 2021 | -9.60 Mn |
| Mar 31, 2021 | -2.86 Mn |
| Mar 31, 2021 | -2.86 Mn |
| Dec 31, 2020 | 4.15 Mn |
| Dec 31, 2020 | 4.15 Mn |
| Sep 30, 2020 | -13.56 Mn |
| Sep 30, 2020 | -13.56 Mn |
| Jun 30, 2020 | -23.73 Mn |
| Jun 30, 2020 | -23.73 Mn |
| Mar 31, 2020 | -29.25 Mn |
| Mar 31, 2020 | -29.25 Mn |
| Dec 31, 2019 | 4.48 Mn |
| Dec 31, 2019 | 4.48 Mn |
| Sep 30, 2019 | -30.52 Mn |
| Sep 30, 2019 | -30.52 Mn |
| Jun 30, 2019 | -18.90 Mn |
| Jun 30, 2019 | -18.90 Mn |
| Mar 31, 2019 | -22.39 Mn |
| Mar 31, 2019 | -22.39 Mn |
| Dec 31, 2018 | -1.78 Mn |
| Dec 31, 2018 | -1.78 Mn |
| Sep 30, 2018 | -13.56 Mn |
| Sep 30, 2018 | -13.56 Mn |
| Jun 30, 2018 | -11.53 Mn |
| Jun 30, 2018 | -11.53 Mn |
| Mar 31, 2018 | 2.02 Mn |
| Mar 31, 2018 | 2.02 Mn |
| Dec 31, 2017 | 1.59 Mn |
| Dec 31, 2017 | 1.59 Mn |
| Sep 30, 2017 | -530,000.00 |
| Sep 30, 2017 | -530,000.00 |
| Jun 30, 2017 | -3.33 Mn |
| Jun 30, 2017 | -3.33 Mn |
| Mar 31, 2017 | 1.55 Mn |
| Mar 31, 2017 | 1.55 Mn |
| Dec 31, 2016 | 2.70 Mn |
| Dec 31, 2016 | 2.70 Mn |
| Sep 30, 2016 | -2.16 Mn |
| Sep 30, 2016 | -2.16 Mn |
| Jun 30, 2016 | 6.53 Mn |
| Jun 30, 2016 | 6.53 Mn |
| Mar 31, 2016 | -12.74 Mn |
| Mar 31, 2016 | -12.74 Mn |
| Dec 31, 2015 | 8.13 Mn |
| Dec 31, 2015 | 8.13 Mn |
| Sep 30, 2015 | -241,365.82 |
| Sep 30, 2015 | -241,365.82 |
| Jun 30, 2015 | -11.36 Mn |
| Jun 30, 2015 | -11.36 Mn |
| Mar 31, 2015 | 11.18 Mn |
| Mar 31, 2015 | 11.18 Mn |
| Dec 31, 2014 | -952,373.11 |
| Dec 31, 2014 | -952,373.11 |